A Utah lab helped make it possible to ask what any mammalian gene does by removing it on purpose.

Capecchi Gene Targeting and the Knockout Mouse

work concluded confidence: Medium status: Draft updated 2026-07-14

Type
work
Status
Draft
Confidence
Medium
Tier
S
Builder-tier
S
Activity-signal
2007 · https://www.nobelprize.org/prizes/medicine/2007/press-release/
Activity-checked
2026-08-14
Focus
gene targeting, knockout mice, biomedical research, genetics
Era
1973-present; core breakthrough in the 1980s; Nobel Prize in 2007
Primary Location
University of Utah, Salt Lake City, UT
Utah Location
University of Utah, Salt Lake City, UT
Updated
2026-07-14
Domain
health-bio
Region
Salt Lake City
Map Location
University of Utah, 201 Presidents Circle, Salt Lake City, UT 84112
Coordinates
40.7644827, -111.8503646
Location Precision
exact
Location Source
https://www.google.com/maps/search/?api=1&query=University+of+Utah+201+Presidents+Circle+Salt+Lake+City+UT+84112
Website
https://www.nobelprize.org/prizes/medicine/2007/press-release/

Summary

Mario Capecchi's University of Utah work made it possible to disable a chosen gene in a living mouse and observe the result. Knockout mice permanently changed causal biology across cancer, development, immunity, metabolism, and neuroscience, with later genome editing building on the same experimental logic.

Impact

Knockout mice changed how biologists asked causal questions. Instead of waiting for natural mutations or using random mutagenesis, researchers could disable a chosen gene and observe development, physiology, disease, and drug response in a whole organism. Cancer, neurodegeneration, cardiovascular disease, immunology, metabolic disease, and developmental biology all absorbed the tool.

The intellectual move also anticipates later genome editing. CRISPR uses different molecular machinery and is often faster, but the basic experimental logic is familiar: choose a genomic target, alter it deliberately, and use the resulting organism or cell to learn function.

What It Took

The hard technical problem was rarity. Homologous recombination in mammalian cells happens infrequently, and random DNA integration is much easier than a precise replacement at the intended locus. Capecchi's positive-negative selection strategy helped separate correctly targeted cells from the much larger background of incorrect integrations.

The work also required a full pipeline: engineered constructs, embryonic stem cells, selection, chimeric mice, breeding, and phenotyping. The outcome was not a single device or product but a reusable research method.

Utah Context

The University of Utah gave Capecchi a long research home, and the story remains one of the strongest examples of basic biology in Utah changing global medicine indirectly. It connects to Utah's later life-sciences ecosystem, but its main importance is scientific: it made Utah part of the everyday experimental toolkit of molecular biology and drug discovery.

Caveats

The Nobel was shared for good reason. Evans's embryonic stem-cell work and Smithies's independent homologous-recombination work were essential. Knockout mice are also slow and expensive, and CRISPR has displaced some older workflows. The lasting claim is not that the original technique remains the fastest tool, but that it opened the precision mammalian genetics era.

Evidence

Open Questions

  • Which primary source most clearly documents the positive-negative selection mechanism?